Tang Yong Qun - Net Worth and Insider Trading
Tang Yong Qun Net Worth
The estimated net worth of Tang Yong Qun is at least $3.5 Billion dollars as of 2025-04-18. Tang Yong Qun is the Director of Nanjing King-Friend Biochemical Pharmaceutical Co Ltd and owns about 319,885,249 shares of Nanjing King-Friend Biochemical Pharmaceutical Co Ltd (SHSE:603707) stock worth over $3.5 Billion. Details can be seen in Tang Yong Qun's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Tang Yong Qun has not made any transactions after 2022-07-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Tang Yong Qun
Tang Yong Qun Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Tang Yong Qun owns 1 companies in total, including Nanjing King-Friend Biochemical Pharmaceutical Co Ltd (SHSE:603707) .
Click here to see the complete history of Tang Yong Qun’s form 4 insider trades.
Insider Ownership Summary of Tang Yong Qun
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
SHSE:603707 | Nanjing King-Friend Biochemical Pharmaceutical Co Ltd | 2022-07-11 | Director |
Tang Yong Qun Latest Holdings Summary
Tang Yong Qun currently owns a total of 1 stock. Tang Yong Qun owns 319,885,249 shares of Nanjing King-Friend Biochemical Pharmaceutical Co Ltd (SHSE:603707) as of July 11, 2022, with a value of $3.5 Billion.
Latest Holdings of Tang Yong Qun
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SHSE:603707 | Nanjing King-Friend Biochemical Pharmaceutical Co Ltd | 2022-07-11 | 319,885,249 | 10.95 | 3,502,743,477 |
Holding Weightings of Tang Yong Qun
Tang Yong Qun Form 4 Trading Tracker
According to the SEC Form 4 filings, Tang Yong Qun has made a total of 2 transactions in Nanjing King-Friend Biochemical Pharmaceutical Co Ltd (SHSE:603707) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Nanjing King-Friend Biochemical Pharmaceutical Co Ltd is the sale of 73,819,673 shares on July 11, 2022, which brought Tang Yong Qun around $0.
Insider Trading History of Tang Yong Qun
- 1
Tang Yong Qun Trading Performance
GuruFocus tracks the stock performance after each of Tang Yong Qun's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Tang Yong Qun is 1.42%. GuruFocus also compares Tang Yong Qun's trading performance to market benchmark return within the same time period. The performance of stocks bought by Tang Yong Qun within 3 months outperforms 3 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Tang Yong Qun's insider trading performs compared to the benchmark.
Performance of Tang Yong Qun
Tang Yong Qun Ownership Network
Ownership Network List of Tang Yong Qun
Ownership Network Relation of Tang Yong Qun

Tang Yong Qun Owned Company Details
What does Nanjing King-Friend Biochemical Pharmaceutical Co Ltd do?
Who are the key executives at Nanjing King-Friend Biochemical Pharmaceutical Co Ltd?
Tang Yong Qun is the Director of Nanjing King-Friend Biochemical Pharmaceutical Co Ltd. Other key executives at Nanjing King-Friend Biochemical Pharmaceutical Co Ltd include Supervisors Liu Zu Qing , senior management Wu Gui Ping , and senior management Qian Xiao Jie .
Nanjing King-Friend Biochemical Pharmaceutical Co Ltd (SHSE:603707) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Nanjing King-Friend Biochemical Pharmaceutical Co Ltd (SHSE:603707) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nanjing King-Friend Biochemical Pharmaceutical Co Ltd (SHSE:603707) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Nanjing King-Friend Biochemical Pharmaceutical Co Ltd (SHSE:603707)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nanjing King-Friend Biochemical Pharmaceutical Co Ltd Insider Transactions
Tang Yong Qun Mailing Address
Above is the net worth, insider trading, and ownership report for Tang Yong Qun. Currently GuruFocus does not have mailing address information for Tang Yong Qun.